These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4621411)

  • 1. Preparation of vaccines for Rocky Mountain spotted fever from rickettsiae propagated in cell culture.
    Kenyon RH; Acree WM; Wright GG; Melchior FW
    J Infect Dis; 1972 Feb; 125(2):146-52. PubMed ID: 4621411
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of three rocky mountain spotted fever vaccines.
    Kenyon RH; Sammons LS; Pedersen CE
    J Clin Microbiol; 1975 Oct; 2(4):300-4. PubMed ID: 810494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.
    Kenyon RH; Pedersen CE
    J Clin Microbiol; 1975 Jun; 1(6):500-3. PubMed ID: 809483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rocky Mountain spotted fever vaccine: a regional need.
    Walker DH; Montenegro MR; Hegarty BC; Tringali GR
    South Med J; 1984 Apr; 77(4):447-9. PubMed ID: 6424239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of guinea pigs from experimental Rocky Mountain spotted fever with a cloned antigen of Rickettsia rickettsii.
    McDonald GA; Anacker RL; Mann RE; Milch LJ
    J Infect Dis; 1988 Jul; 158(1):228-31. PubMed ID: 3134494
    [No Abstract]   [Full Text] [Related]  

  • 6. "Rickettsia amblyommii" induces cross protection against lethal Rocky Mountain spotted fever in a guinea pig model.
    Blanton LS; Mendell NL; Walker DH; Bouyer DH
    Vector Borne Zoonotic Dis; 2014 Aug; 14(8):557-62. PubMed ID: 25072985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rickettsiae: a new vaccine for Rocky Mountain spotted fever.
    Maugh TH
    Science; 1978 Aug; 201(4356):604. PubMed ID: 97783
    [No Abstract]   [Full Text] [Related]  

  • 8. Extraction of protective components of Rickettsia rickettsii with n-octyl-beta-D-glucopyranoside.
    McDonald GA; Anacker RL; Mann RE
    Rev Infect Dis; 1988; 10 Suppl 2():S382-5. PubMed ID: 3142019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of Rickettsia rickettsii in Rocky Mountain Spotted Fever Outbreak, Panama.
    Zaldívar Y; Hernández M; Domínguez L; Saénz L; Montilla S; de Antinori MEB; Krawczak FS; Bermúdez S
    Emerg Infect Dis; 2021 Apr; 27(4):1245-1247. PubMed ID: 33755006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rocky Mountain spotted fever vaccine in an animal model.
    Folds JD; Walker DH; Hegarty BC; Banasiak D; Lange JV
    J Clin Microbiol; 1983 Aug; 18(2):321-6. PubMed ID: 6413529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New assay of protective activity of Rocky Mountain spotted fever vaccines.
    Anacker RL; Smith RF; Mann RE; Hamilton MA
    J Clin Microbiol; 1976 Sep; 4(3):309-11. PubMed ID: 823177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii.
    DuPont HL; Hornick RB; Dawkins AT; Heiner GG; Fabrikant IB; Wisseman CL; Woodward TE
    J Infect Dis; 1973 Sep; 128(3):340-4. PubMed ID: 4199563
    [No Abstract]   [Full Text] [Related]  

  • 13. Rocky Mountain spotted fever. Laboratory infection in a vaccinated individual.
    Calia FM; Bartelloni PJ; McKinney RW
    JAMA; 1970 Mar; 211(12):2012-4. PubMed ID: 4984704
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever.
    Clements ML; Wisseman CL; Woodward TE; Fiset P; Dumler JS; McNamee W; Black RE; Rooney J; Hughes TP; Levine MM
    J Infect Dis; 1983 Nov; 148(5):922-30. PubMed ID: 6415182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice.
    Gong W; Xiong X; Qi Y; Jiao J; Duan C; Wen B
    Vaccine; 2014 Apr; 32(18):2027-33. PubMed ID: 24582636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of guinea pigs to Rickettsia rickettsii by aerosol, nasal, conjunctival, gastric, and subcutaneous routes and protection afforded by an experimental vaccine.
    Kenyon RH; Kishimoto RA; Hall WC
    Infect Immun; 1979 Aug; 25(2):580-2. PubMed ID: 114488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rocky Mountain spotted fever and the avoidance of sulfonamides.
    Steigman AJ
    J Pediatr; 1977 Jul; 91(1):163-4. PubMed ID: 406374
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of guinea-pigs from experimental Rocky Mountain spotted fever by immunization with baculovirus-expressed Rickettsia rickettsii rOmpA protein.
    Sumner JW; Sims KG; Jones DC; Anderson BE
    Vaccine; 1995 Jan; 13(1):29-35. PubMed ID: 7762273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever.
    Vishwanath S; McDonald GA; Watkins NG
    Infect Immun; 1990 Mar; 58(3):646-53. PubMed ID: 2106490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of a heterologous recombinant Sca5/OmpB protein-based vaccine to elicit effective protective immunity against Rickettsia rickettsii infections in C3H/HeN mice.
    Riley SP; Cardwell MM; Chan YG; Pruneau L; Del Piero F; Martinez JJ
    Pathog Dis; 2015 Dec; 73(9):ftv101. PubMed ID: 26519448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.